In the Framingham Offspring cohort (2,308 adults, mean age 61.5; 1,148 dementia-free adults aged 60+ followed 10 years), each standard-deviation slowdown in quick walking speed (QWS) tracked with worse executive function, higher odds of elevated depressive symptoms (OR 1.24), and greater stroke hazard (HR 1.30). Slower QWS also predicted incident dementia (HR 1.34), while usual walking speed (UWS) fell short of significance (HR 1.20, 95% CI 0.98-1.46). Smaller gait adaptability (QWS minus UWS) predicted dementia in women only (HR 1.35).
Gait speed is already a recognized vital sign for older adults, but this work suggests the standard habitual-pace test may leave signal on the table: asking people to walk as fast as they safely can taps physiological reserve that comfortable walking masks. The practical appeal is obvious, since a timed fast-walk adds seconds to an existing clinic assessment. Caveats matter, though. The UWS and QWS dementia estimates overlap heavily, so the claim that one outperforms the other is weaker than the headline contrast implies. The sex-specific findings come from subgroup analyses that risk chance results. Slow walking may also be an early symptom of preclinical disease rather than a cause, and the cohort is largely white and middle-class. This is a preprint, not yet peer reviewed, so estimates may shift. Overall, this is an incremental extension of established gait-speed literature, not a paradigm shift. It supports faster-pace testing as a cheap screening add-on, not as proof that walking faster protects the brain.